Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 04 2022
Historique:
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

Carotid atherosclerosis and microalbuminuria are associated with atherosclerotic cardiovascular disease (ASCVD) but are understudied in sub-Saharan Africa. To evaluate the association of carotid atherosclerosis and microalbuminuria with 10-year ASCVD risk in middle-aged sub-Saharan African individuals. This cross-sectional study conducted analyses of baseline data from the African-Wits-INDEPTH (International Network for the Demographic Evaluation of Populations and Their Health in Low- and Middle-Income Countries) genomic study (AWI-Gen). Women and men aged 40 to 60 years without baseline CVD and drawn from Burkina Faso, Ghana, Kenya, and South Africa were included. Hypotheses for the analyses were formulated after data collection. The main exposures were carotid atherosclerosis, assessed using carotid intima-media thickness (CIMT) using B-mode ultrasonography, and microalbuminuria, measured using spot urine albumin (SUA) and urine albumin-creatinine ratio (uACR). The main outcome was high ASCVD risk, defined as a 2018 Pooled Cohort Equations score of 7.5% or greater. Associations were estimated using adjusted multivariable logistic regression analyses. A total of 9010 participants with a mean (SD) age of 50 (6) years and 4533 (50.3%) women were included. High CIMT, SUA, and uACR were each associated with older age (eg, mean [SD] age of participants with high vs reference range CIMT: 55 [5] years vs 50 [6] years; P < .001) and high prevalence of both diabetes and hypertension (eg, hypertension among those with high vs reference range SUA: 213 of 1117 [19.1%] vs 356 of 2549 [14.0%]; P < .001). Smokers were likely to have higher vs reference range SUA (210 [18.8%] vs 407 [16.0%]) and uACR (138 of 707 [19.5%] vs 456 of 2797 [16.3%]). Carotid atherosclerosis was common in Burkina Faso (82 of 262 [31.3%]) and Ghana (91 [34.7%]), while microalbuminuria, measured by SUA, was common in Kenya (272 [24.4%]) and South Africa (519 [46.5%]). SUA was associated with higher odds of carotid atherosclerosis (odds ratio [OR], 1.77; 95% CI, 1.04-3.01) compared with uACR (OR, 0.51; 95% CI, 0.27-0.95). Common CIMT, SUA, and uACR were associated with 10-year ASCVD risk, with CIMT having a stronger association with 10-year ASCVD risk in both women (OR, 1.95; 95% CI, 1.78-2.14) and men (OR, 1.73; 95% CI, 1.55-1.93) than SUA (women: OR, 1.29; 95% CI, 1.12-1.43; men: OR, 1.46; 95% CI, 1.26-1.55) and uACR (women: OR, 1.32; 95% CI, 1.10-1.54; men: OR, 1.35; 95% CI, 1.15-1.46). The presence of microalbuminuria measured by SUA may indicate risk of subclinical carotid atherosclerosis and high 10-year ASCVD risk in middle-aged residents of sub-Saharan Africa. These data should be confirmed in longitudinal studies of cardiovascular events.

Identifiants

pubmed: 35471573
pii: 2791534
doi: 10.1001/jamanetworkopen.2022.7559
pmc: PMC9044117
doi:

Substances chimiques

Albumins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e227559

Subventions

Organisme : NHGRI NIH HHS
ID : U54 HG006938
Pays : United States

Références

JAMA. 2001 Jul 25;286(4):421-6
pubmed: 11466120
Glob Health Action. 2018;11(sup2):1507133
pubmed: 30259792
Lancet. 2020 Mar 7;395(10226):795-808
pubmed: 31492503
Eur Heart J. 2002 Jun;23(12):934-40
pubmed: 12069447
J Korean Med Sci. 2013 Mar;28(3):409-14
pubmed: 23487182
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Nephrol Dial Transplant. 2004 Apr;19(4):778-81
pubmed: 15031329
Front Physiol. 2018 Jun 22;9:739
pubmed: 29988372
Am J Epidemiol. 1997 Sep 15;146(6):483-94
pubmed: 9290509
J Intern Med. 1991 Mar;229(3):225-31
pubmed: 2007840
Am J Epidemiol. 2000 Mar 1;151(5):478-87
pubmed: 10707916
Cerebrovasc Dis. 2012;34(4):290-6
pubmed: 23128470
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Diabetologia. 1993 Oct;36(10):1030-6
pubmed: 8243851
J Am Soc Nephrol. 2006 Sep;17(9):2582-90
pubmed: 16899519
AIDS. 2007 May 11;21(8):1003-9
pubmed: 17457094
Glob Health Epidemiol Genom. 2016 Nov 22;1:e20
pubmed: 29276616
Chin Med J (Engl). 2016 Jan 20;129(2):215-26
pubmed: 26830994
Am J Nephrol. 2013;37(5):443-51
pubmed: 23615312
JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38
pubmed: 25051948
Adv Chronic Kidney Dis. 2015 Jan;22(1):24-30
pubmed: 25573509
J Clin Invest. 2004 Nov;114(10):1412-4
pubmed: 15545991
PLoS One. 2015 Aug 26;10(8):e0136529
pubmed: 26309226
BMC Nephrol. 2012 Jun 11;13:37
pubmed: 22686733
J Am Coll Cardiol. 2012 Oct 23;60(17):1599-604
pubmed: 22999720
J Clin Epidemiol. 2007 Oct;60(10):1067-75
pubmed: 17884603
JAMA Intern Med. 2017 Aug 1;177(8):1165-1172
pubmed: 28604921
Int J Epidemiol. 2016 Apr;45(2):305-8
pubmed: 26659658
BMC Public Health. 2021 Jun 12;21(1):1126
pubmed: 34118914
Eur Heart J. 2007 Feb;28(3):363-9
pubmed: 17132646
Nephrol Dial Transplant. 2002 Jan;17(1):81-5
pubmed: 11773468
Am Heart J. 2001 May;141(5):711-21
pubmed: 11320357
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Hawaii J Med Public Health. 2013 Sep;72(9 Suppl 4):34-8
pubmed: 24052917
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959
pubmed: 24239921
Circulation. 2002 Mar 5;105(9):1135-43
pubmed: 11877368
Ann Intern Med. 2018 Jul 3;169(1):20-29
pubmed: 29868850
PLoS One. 2015 Jul 02;10(7):e0132321
pubmed: 26134404
Glob Heart. 2020 Feb 12;15(1):15
pubmed: 32489788
Lancet Glob Health. 2019 Dec;7(12):e1632-e1643
pubmed: 31708144
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
J Am Soc Nephrol. 2006 Aug;17(8):2106-11
pubmed: 16825333
J Cardiovasc Ultrasound. 2010 Dec;18(4):134-8
pubmed: 21253362

Auteurs

Engelbert A Nonterah (EA)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Daniel Boateng (D)

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Nigel J Crowther (NJ)

Department of Chemical Pathology, National Laboratory Health Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Kerstin Klipstein-Grobusch (K)

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Abraham R Oduro (AR)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.

Godfred Agongo (G)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Department of Biochemistry and Forensic Sciences, School of Chemical and Biochemical Sciences, C.K. Tedam University of Technology and Applied Sciences, Navrongo, Ghana.

Shukri F Mohamed (SF)

African Population Health Research Centre, Nairobi, Kenya.

Palwendé R Boua (PR)

Institut de Recherché en Sciences de la Santé, Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Solomon S R Choma (SSR)

DIMAMO Health Demographic Surveillance Site, Department of Pathology and Medical Sciences, School of Health Care Sciences, Faculty of Health Sciences, University of Limpopo, Polokwane, South Africa.

Shane A Norris (SA)

MRC/Wits Developmental Pathways for Health Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Stephen M Tollman (SM)

MRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Michiel L Bots (ML)

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Michèle Ramsay (M)

Sydney Brenner Institute of Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Diederick Grobbee (D)

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH